Navigation Links
Astellas Named Elite Winner for Employee Engagement and Commitment in 'Chicago's 101 Best and Brightest Companies to Work For' Competition
Date:8/11/2009

DEERFIELD, Ill., Aug. 11 /PRNewswire/ -- In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association for Business Resources (NABR). Astellas scored high in all 10 categories and was specifically recognized for the high level of employees' engagement and pride in the company.

"At Astellas, we understand that investment in our employees is vital to reaching our corporate goals and it is even more critical in these tough economic times," said Seigo Kashii, president and CEO of Astellas. "Being selected as 'Chicago's 101 Best and Brightest Companies to Work For' further validates our commitment to our employees and being a recognized employer of choice in the Chicago area and the pharmaceutical industry."

"We are honored to recognize the efforts of this year's 101 'Best and Brightest' companies. These companies have created impressive organizational value and business results through their policies and best practices in human resource management. This award has become a powerful recruitment tool in the drive to attract and retain exceptional employees," said Jennifer Kluge, NABR president.

The NABR's annual list of "Best and Brightest Companies" compiles the results of an independent research firm that evaluates each company's entry in the following categories: communication, community initiatives, compensation and benefits, diversity and multiculturalism, employee education and development, employee engagement and commitment, recognition and retention, small business, recruitment and selection, and work-life balance. The judges look for unique and creative thought processes with support from senior management and policy makers.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Astellas Hires New Vice President of Compliance
7. Astellas Adds CNS Therapy Area Leader to Global R&D Team
8. Astellas Names Head of Global R&D Operations
9. NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
10. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
11. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...up to one-third buying 90-day supply, study finds ...Buying a three-month supply of prescription drugs ... supply, according to a new study. , U.S. resea...5 drugs between 2000 and 2005, and found that pati...one-month supply saved an average 29 percent in ou...
(Date:11/20/2009)...Project Bread addresses increased food insecurity ... 20 Project Bread, the ... numbers from its upcoming annual status report on...s described in this report, caused by high unemplo... struggling with hunger. Food insecurity has found...
(Date:11/20/2009)...N ROUGE, La., Nov. 20 ...) today warned that Louisianians could experience ...f proposals being considered by Congress should be...utive officer for LAHP, "Louisiana health plans ha...e the beginning of the national debate. Our plans...
(Date:11/20/2009)...A DEL REY, Calif., Nov. 20 Heritag...dent Dr. Richard Merkin, announce that as of Novem...ll as all its affiliated entities, have been acqui...HPN family. ,, "We first and foremost want to a...N family are dedicated to maintaining the high lev...
(Date:11/20/2009)... NEW YORK, Nov. 20 Reportlinker.co...vailable in its catalogue. ,, Oncology Roadmap... 2013 ,, http://www.reportlinker.com/p016499...arket-Forecast-to-2013.html#utm_source=prnewswire&..., Comprehensive Forecasts and Detailed Budget Be...
Breaking Medicine News(10 mins):Health News:Three-Month Supply Lowers Drug Costs 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3
...cripps Health, Qualcomm Join Forces as Founding He...GO, March 30 Gary and Mary West Foundation toda...s Health Institute, one of world,s first medical r...ding health care affiliate, with Qualcomm as a fou...
...tudy Shows New Patient Care Model Significantly Im...arch 29 DaVita Inc., a leading provider of kidney...dney disease (CKD), today released the findings of...ty rates for new dialysis patients. The study pres...
... Pediatric surgeons are able to repair complex he...0 percent, but that doesn,t necessarily mean a hap...have a great quality of life and others, with the ...s with heart disease, including African-Americans ...
...HOUSTON (March 29, 2009) The allergen breathed in...enzyme called MMP7 that activates a cascade of eve...ium of researchers led by Baylor College of Medici...5, a key mediator of the allergic response in the ...
...k appears the same for bare metal or drug-eluting ... (HealthDay News) -- Despite initial concerns that... more common with the drug-eluting device, there a...ents undergo a treatment called angioplasty, which...
... The ZEO Health Ltd. affili... to earn substantial income through sale of produc...ell as demand. ZEO Health has created a risk-free... New York (PRWEB) March 29, ...
Other Medicine News:Health News:Gary and Mary West Foundation Commits $45 Million to Create Wireless Health Institute 2Health News:Gary and Mary West Foundation Commits $45 Million to Create Wireless Health Institute 3Health News:DaVita's IMPACT Program Reduces Mortality for New Dialysis Patients 2Health News:DaVita's IMPACT Program Reduces Mortality for New Dialysis Patients 3Health News:Physicians mending broken hearts 2Health News:No Increase in Clots With Drug-Eluting Stents 2Health News:No Increase in Clots With Drug-Eluting Stents 3Health News:ZEO Health's New Program Offers Answer for Those Looking for Income 2
(Date:11/19/2009)..., Nov. 19 Ligon Discovery, Inc., w...chnology to find drugs against high-value targets,...nancing led by incTANK Ventures. The company will ...campaign that will screen over 100 high-value dise... Ventures General Partner Christian Bailey joins t...
(Date:11/19/2009)...ational Internet Week of Action ,, SILVER SPRI...S. Food and Drug Administration today completed a ...d the International Internet Week of Action (IIWA)...al products. ,, (Logo: http://www.newscom.com/...ffort, the FDA,s Office of Criminal Investigations...
(Date:11/19/2009)... Nov. 19 Breast-Specific Gamma Ima...recognized and endorsed by two highly esteemed org...e Society of Breast Imaging (SBI) and the American...icles supporting the further application of this b...tion of breast cancer. ,, "These endorsements r...
Breaking Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Super sticky barnacle glue cures like blood clots 10391 1Super sticky barnacle glue cures like blood clots 10391 2Super sticky barnacle glue cures like blood clots 10391 3Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Tiny test tube experiment shows reaction of melting materials at the nano scale 14498 1Tiny test tube experiment shows reaction of melting materials at the nano scale 14498 2
...PORT, N.Y., Sept. 5 AGI Dermatics, the bio-,pharm...or skincare,announced today that U.S. Food & Drug ...ation for Dimericine (T4N5) for treatment of solar... Xeroderma Pigmentosum (XP).,Dimericine, also know...oped,by AGI currently in clinical trials for treat...
...AS, Sept. 4 A small reduction in blood,pressure p... ever done on,the treatment of patients with type ...uropean Society of Cardiology Congress, and publis...cMahon, Ph.D., M.P., described the results of ADVA...ch 11,140 patients received,either placebo or a si...
Other Medicine Technology:Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients 2American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure? 2
SureStep Propoxyphene (PPX)
AMPII/BZO300/COC/MAMPII/MOP/THC
SureStep Morphine (MOP)
THC/COC/MOP/AMPII/MAMPII/BZO200
Medicine Products: